VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $220,306 | -31.4% | 103,918 | 0.0% | 0.00% | – |
Q2 2023 | $321,107 | +235.5% | 103,918 | +484.1% | 0.00% | – |
Q1 2023 | $95,721 | +32.4% | 17,792 | +63.6% | 0.00% | – |
Q4 2022 | $72,319 | +64.4% | 10,875 | 0.0% | 0.00% | – |
Q3 2022 | $44,000 | -78.7% | 10,875 | -73.8% | 0.00% | – |
Q2 2022 | $207,000 | -63.4% | 41,476 | -55.7% | 0.00% | – |
Q1 2022 | $566,000 | -47.3% | 93,586 | +1.4% | 0.00% | – |
Q4 2021 | $1,073,000 | -23.5% | 92,335 | +3.2% | 0.00% | – |
Q3 2021 | $1,403,000 | +8.9% | 89,456 | +29.6% | 0.00% | – |
Q2 2021 | $1,288,000 | -59.2% | 69,030 | -5.7% | 0.00% | -100.0% |
Q1 2021 | $3,157,000 | – | 73,241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |